Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.

Daniel A Galvão | Dickon Hayne | Mark Frydenberg | Suzanne K Chambers | Dennis R Taaffe | Nigel Spry | Paul A Scuffham | Robert S Ware | Nicolas H Hart | Robert U Newton
BMJ open | 2018

Active surveillance is a strategy for managing low-risk, localised prostate cancer, where men are observed with serial prostate-specific antigen assessments to identify signs of disease progression. Currently, there are no strategies to support active surveillance compliance nor are there interventions that can prevent or slow disease progression, ultimately delaying transition to active treatment before it is clinically required. Recently, we proposed that exercise may have a therapeutic potential in delaying the need for active treatment in men on active surveillance.

Pubmed ID: 29678994

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ActiGraph Activity Monitor Devices (tool)

RRID:SCR_008399

Commercial instrument supplier for human activity monitors. ActiGraph devices are used by researchers and clinicians in hundreds of universities and research organizations in more than 56 countries. ActiGraph activity monitors are the most validated and widely used devices of their kind. ActiGraph activity monitors use triaxial accelerometers and our validated proprietary filtering algorithms to accurately measure the amount and intensity of human activity. They are powered by rechargeable lithium ion batteries, and battery charging and communication are accomplished via a standard USB connection. All ActiGraph activity monitors can be worn at the waist or wrist and are suitable for subjects of all ages. ActiGraph devices have been used in hundreds of research studies in nearly 60 countries around the world since 1992. Leading research facilities including the U.S. National Institute of Health (NIH), the Institute of Child Health in the UK, and Karolinska Institutet in Sweden rely on our products to provide objective activity measurement in dozens of areas including obesity, diabetes, sleep, elderly behavior, and athletics. ActiGraph often works with scientific organizations to develop and implement software and hardware features that reflect the evolving needs of the research community. ActiGraph devices are well recognized as some of the most accurate activity measurement products on the market. Extensive research has confirmed our accuracy against the VO2 and doubly labeled water (DLW) methods of estimating energy expenditure. Keywords: Device, Researcher, Clinician, University, Research, Organization, Obesity, Diabetes, Sleep, Elderly, Behavior, Athletics, Scientific, Activity monitor, Physical, Measurement, Human, Activity,

View all literature mentions